Creapharm, a Myonex Company
keyboard_backspaceBack to Home
Contact
location_on
23 rue du Roule
75001 PARIS
France
public
SOPHIE LAFON
Associate Director, Marketing
Associate Director, Marketing
call
About us
- Creapharm, a Myonex company, serves pharmaceutical and biotech companies, providing capabilities and flexibility.
- Beyond decades of experience in Clinical and Commercial pharmaceutical packaging, labeling and distribution, we provide a strong expertise in cold-chain management.
- We have recently developed cryogenic solutions to provide an integrated service offering for the supply chain management of biotherapies and Innovative Therapy Medicines (ITMs).
- Our state-of-the-art biobank is located in Bailly-Romainvilliers, near Paris.
- More globally, Myonex is present in the United States, Europe (France and Germany) and the United Kingdom.
Business offer
ATMP Supply Chain management :
- Highly-secured storage from -196°C to ambient
- Packing and labeling opérations at any temperature
- Adapted logistics to biotherapies
- QP services
- Cryopreservation of cell banks, biobanking, biorepository
- Biospecimen Kit Assembly, and logistics for biological samples
- Training, consulting et audits
Activities
- Service
- CMC
- GLP compliance
- Master Cell Bank
- Storage
- Bioproduction
- Batch release
- Storage matter
- Logistic
- Cell cryopreservation
- Controlled-rated freezer
- thaw
- Clinical trials
- Phase I
- Phase II
- Phase III
- Phase IV
- Post-market surveillance
- Post-Market Surveillance
- Bioproduction engineering
- Conditioning
- Storage
- Delivery
- Transport
- Supply chain logistics
- Tracking process
- Monitoring logistics
- Bioproduction/CMC/Analytical Quality Assessment, Quality Control
- Supply chain logistics
- Tracking process
- Monitoring logistics
- CMC
- GMP compliance
- Master Banks (cell and viral as needed)
- storage
- shipment
- Cell Culture / Fermentation
- Ability to work in BSL2 conditions
- Clinical trials
- Phase I
- Phase II (human challenge trials)
- Phase III (large population pending pathogen prevalence)
- Bioproduction GMP
- Manufacturing Volume
- Commercial supply during life cycle management
- Post-market surveillance
- Clinical Trial phase IV
Categories
Therapeutic applications
Expertises
Directory of Antibodies, Recombinant proteins and others
Cell Therapy Directory
Gene and CAR-T cell therapy Directory
Prophylactic Vaccines Directory
